Chong Kun Dang Pharmaceutical Corp. | Ownership
Companies that own Chong Kun Dang Pharmaceutical Corp.
National Pension Service of Korea
1,083,710
10.97%
-49,463
0.08%
06/29/2018
ABL GLOBAL ASSET MANAGEMENT Co., Ltd.
329,505
3.34%
-216,476
5.45%
07/31/2017
The Vanguard Group, Inc.
146,899
1.49%
1
0%
07/31/2018
Dimensional Fund Advisors LP
108,445
1.1%
1,633
0%
04/30/2018
Norges Bank Investment Management
106,355
1.08%
-7,890
0%
12/31/2017
BlackRock Fund Advisors
64,879
0.66%
0
0%
09/05/2018
Mirae Asset Global Investments Co., Ltd.
55,735
0.56%
-516
0.05%
04/30/2018
Victory Capital Management, Inc.
55,054
0.56%
6,708
0.01%
06/30/2018
Fisher Asset Management LLC
28,943
0.28%
6,683
0%
05/31/2018
TIAA-CREF Investment Management LLC
27,685
0.28%
0
0%
03/31/2018
| Address |
8 Chungjeong-ro
Seoul SL 03742
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.ckdpharm.com |
| Updated |
07/08/2019 |
| Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetic, antivirus, beta-blocking, anti-hyperlipidemia and others. The company was founded on November 2, 2013 and is headquartered in Seoul, South Korea. |
